What is the primary purpose of this 8-K filing?

This 8-K filing announces the definitive Agreement and Plan of Merger between Anthem, Inc. and Cigna Corporation, outlining the terms and conditions of their proposed merger.

What will Cigna shareholders receive in the merger?

Cigna shareholders will receive $103.40 in cash and 0.5152 shares of Anthem common stock for each share of Cigna common stock they own.

How will the combined company be financed?

Anthem has secured a commitment for a $26.5 billion 364-day senior unsecured bridge term loan credit facility to help finance the merger, should other financing methods not be sufficient.

What are the key conditions for the merger to be completed?

The merger is subject to several conditions, including approval by the shareholders of both Anthem and Cigna, receipt of necessary governmental and regulatory approvals without burdensome conditions, and listing of Anthem's shares on the NYSE.

Are there significant financial penalties for terminating the deal?

Yes, the merger agreement includes substantial termination fees. A termination fee of $1.85 billion is payable under certain circumstances, such as if either party enters into an agreement for a superior proposal or if the board changes its recommendation. An expense fee of $600 million is also stipulated if shareholder approval is not obtained.

ELV 8-K: Material Agreements

Summary

Elevance Health, Inc. (formerly Anthem, Inc.) announced a significant corporate event via an 8-K filing on July 27, 2015, detailing the entry into a definitive Agreement and Plan of Merger with Cigna Corporation. This agreement outlines a merger where Anthem, Inc. will acquire Cigna Corporation in a transaction valued at approximately $54 billion. The deal is structured as a reverse triangular merger followed by a statutory merger, intended to qualify as a tax-free reorganization. The Merger Consideration for Cigna stockholders will be a combination of cash ($103.40 per share) and stock (0.5152 shares of Anthem common stock per share). This strategic move aims to create a larger, more comprehensive health benefits organization. The filing also details the financing for the transaction, including a significant bridge loan commitment of up to $26.5 billion from a syndicate of banks, underscoring the scale of the acquisition. The merger agreement includes customary provisions such as representations, warranties, covenants, and termination rights, with substantial termination fees for either party under specific circumstances. The integration of leadership is also addressed, with plans to expand Anthem's board and key executive roles. Investors should note the forward-looking statements and associated risks, as well as the significant regulatory and shareholder approvals required for closing.

Key Highlights

1Anthem, Inc. entered into a definitive Agreement and Plan of Merger with Cigna Corporation on July 23, 2015.
2The transaction involves the acquisition of Cigna by Anthem in a cash and stock deal.
3Cigna shareholders will receive $103.40 in cash and 0.5152 shares of Anthem common stock per share.
4The combined entity will continue under the name Anthem, Inc. (later to become Elevance Health).
5Anthem secured a commitment for a $26.5 billion bridge loan facility to finance the merger.
6The merger agreement includes significant termination fees, totaling $1.85 billion under certain conditions.
7The transaction is subject to customary closing conditions, including regulatory and shareholder approvals from both companies.

Elevance Health, Inc. 8-K Report, Material Agreement (Jul 27, 2015)

Summary

Key Highlights

Frequently Asked Questions